Semen CD4 T Cells and Macrophages Are Productively Infected at All Stages of SIV infection in Macaques
The mucosal events of HIV transmission have been extensively studied, but the role of infected cells present in the genital and rectal secretions, and in the semen, in particular, remains a matter of debate. As a prerequisite to a thorough in vivo investigation of the early transmission events through infected cells, we characterized in detail by multi-parameter flow cytometry the changes in macaque seminal leukocytes during SIVmac251 infection, focusing on T cells, macrophages and dendritic cells. Using immunocytofluorescence targeting SIV proteins and real-time quantitative PCR targeting SIV DNA, we investigated the nature of the infected cells on sorted semen leukocytes from macaques at different stages of infection. Finally, we cocultured semen CD4+ T cells and macrophages with a cell line permissive to SIV infection to assess their infectivity in vitro. We found that primary infection induced strong local inflammation, which was associated with an increase in the number of leukocytes in semen, both factors having the potential to favor cell-associated virus transmission. Semen CD4+ T cells and macrophages were productively infected at all stages of infection and were infectious in vitro. Lymphocytes had a mucosal phenotype and expressed activation (CD69 & HLA-DR) and migration (CCR5, CXCR4, LFA-1) markers. CD69 expression was increased in semen T cells by SIV infection, at all stages of infection. Macrophages predominated at all stages and expressed CD4, CCR5, MAC-1 and LFA-1. Altogether, we demonstrated that semen contains the two major SIV-target cells (CD4+ T cells and macrophages). Both cell types can be productively infected at all stages of SIV infection and are endowed with markers that may facilitate transmission of infection during sexual exposure.
Vyšlo v časopise:
Semen CD4 T Cells and Macrophages Are Productively Infected at All Stages of SIV infection in Macaques. PLoS Pathog 9(12): e32767. doi:10.1371/journal.ppat.1003810
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003810
Souhrn
The mucosal events of HIV transmission have been extensively studied, but the role of infected cells present in the genital and rectal secretions, and in the semen, in particular, remains a matter of debate. As a prerequisite to a thorough in vivo investigation of the early transmission events through infected cells, we characterized in detail by multi-parameter flow cytometry the changes in macaque seminal leukocytes during SIVmac251 infection, focusing on T cells, macrophages and dendritic cells. Using immunocytofluorescence targeting SIV proteins and real-time quantitative PCR targeting SIV DNA, we investigated the nature of the infected cells on sorted semen leukocytes from macaques at different stages of infection. Finally, we cocultured semen CD4+ T cells and macrophages with a cell line permissive to SIV infection to assess their infectivity in vitro. We found that primary infection induced strong local inflammation, which was associated with an increase in the number of leukocytes in semen, both factors having the potential to favor cell-associated virus transmission. Semen CD4+ T cells and macrophages were productively infected at all stages of infection and were infectious in vitro. Lymphocytes had a mucosal phenotype and expressed activation (CD69 & HLA-DR) and migration (CCR5, CXCR4, LFA-1) markers. CD69 expression was increased in semen T cells by SIV infection, at all stages of infection. Macrophages predominated at all stages and expressed CD4, CCR5, MAC-1 and LFA-1. Altogether, we demonstrated that semen contains the two major SIV-target cells (CD4+ T cells and macrophages). Both cell types can be productively infected at all stages of SIV infection and are endowed with markers that may facilitate transmission of infection during sexual exposure.
Zdroje
1. HaigwoodNL (2004) Predictive value of primate models for AIDS. AIDS Rev 6: 187–198.
2. VeazeyRS, ShattockRJ, KlassePJ, MooreJP (2012) Animal models for microbicide studies. Curr HIV Res 10: 79–87.
3. AndersonDJ, PolitchJA, NadolskiAM, BlaskewiczCD, PudneyJ, et al. (2010) Targeting Trojan Horse leukocytes for HIV prevention. AIDS 24: 163–187.
4. PolitchJA, MayerKH, AndersonDJ (2009) Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 50: 283–289.
5. AndersonDJ, YunisEJ (1983) “Trojan Horse” leukocytes in AIDS. N Engl J Med 309: 984–985.
6. AlfsenA, YuH, Magerus-ChatinetA, SchmittA, BomselM (2005) HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 16: 4267–4279.
7. GrootF, WelschS, SattentauQJ (2008) Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 111: 4660–4663.
8. BomselM (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3: 42–47.
9. GanorY, ZhouZ, TudorD, SchmittA, Vacher-LavenuMC, et al. (2010) Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 3: 506–522.
10. GanorY, ZhouZ, BodoJ, TudorD, LeibowitchJ, et al. (2012) The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages. Mucosal Immunol 6: 776–86.
11. HladikF, SakchalathornP, BallweberL, LentzG, FialkowM, et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257–270.
12. Di FabioS, GianniniG, LapentaC, SpadaM, BinelliA, et al. (2001) Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS 15: 2231–2238.
13. SalleB, BrochardP, BourryO, ManniouiA, AndrieuT, et al. (2010) Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis 202: 337–344.
14. Le TortorecA, Le GrandR, DenisH, SatieAP, ManniouiK, et al. (2008) Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One 3: e1792.
15. KaizuM, WeilerAM, WeisgrauKL, VielhuberKA, MayG, et al. (2006) Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J Infect Dis 194: 912–916.
16. BaetenJM, KahleE, LingappaJR, CoombsRW, Delany-MoretlweS, et al. (2011) Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3: 77ra29.
17. TachetA, DulioustE, SalmonD, De AlmeidaM, RivallandS, et al. (1999) Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13: 823–831.
18. CoombsRW, SpeckCE, HughesJP, LeeW, SampoleoR, et al. (1998) Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 177: 320–330.
19. VernazzaPL, DyerJR, FiscusSA, EronJJ, CohenMS (1997) HIV-1 viral load in blood, semen and saliva. AIDS 11: 1058–1059.
20. Van VoorhisBJ, MartinezA, MayerK, AndersonDJ (1991) Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques. Fertil Steril 55: 588–594.
21. MerminJH, HolodniyM, KatzensteinDA, MeriganTC (1991) Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 164: 769–772.
22. HamedKA, WintersMA, HolodniyM, KatzensteinDA, MeriganTC (1993) Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J Infect Dis 167: 798–802.
23. QuayleAJ, XuC, MayerKH, AndersonDJ (1997) T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 176: 960–968.
24. XuC, PolitchJA, TuckerL, MayerKH, SeageGR3rd, et al. (1997) Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 176: 941–947.
25. KriegerJN, NirapathpongpornA, ChaiyapornM, PetersonG, NikolaevaI, et al. (1998) Vasectomy and human immunodeficiency virus type 1 in semen. J Urol 159: 820–825; discussion 825–826.
26. MayerKH, BoswellS, GoldsteinR, LoW, XuC, et al. (1999) Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 28: 1252–1259.
27. VernazzaPL, TroianiL, FleppMJ, ConeRW, SchockJ, et al. (2000) Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 14: 117–121.
28. GhosnJ, ViardJP, KatlamaC, de AlmeidaM, TubianaR, et al. (2004) Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS 18: 447–457.
29. MattapallilJJ, DouekDC, HillB, NishimuraY, MartinM, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093–1097.
30. BrenchleyJM, HillBJ, AmbrozakDR, PriceDA, GuenagaFJ, et al. (2004) T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78: 1160–1168.
31. VeazeyRS, MansfieldKG, ThamIC, CarvilleAC, ShvetzDE, et al. (2000) Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 74: 11001–11007.
32. JollyC, KashefiK, HollinsheadM, SattentauQJ (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199: 283–293.
33. RudnickaD, FeldmannJ, PorrotF, WietgrefeS, GuadagniniS, et al. (2009) Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 83: 6234–6246.
34. VeazeyRS, ThamIC, MansfieldKG, DeMariaM, ForandAE, et al. (2000) Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol 74: 57–64.
35. MillerCJ (1994) Animal models of viral sexually transmitted diseases. Am J Reprod Immunol 31: 52–63.
36. LacknerAA, VeazeyRS (2007) Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med 58: 461–476.
37. ManniouiA, BourryO, SellierP, DelacheB, BrochardP, et al. (2009) Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques. Retrovirology 6: 106.
38. MillerCJ, MarthasM, GreenierJ, LuD, DaileyPJ, et al. (1998) In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J Virol 72: 3248–3258.
39. HladikF, LentzG, DelpitE, McElroyA, McElrathMJ (1999) Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J Immunol 163: 2306–2313.
40. PrakashM, KapembwaMS, GotchF, PattersonS (2001) Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J Reprod Immunol 52: 101–111.
41. LehnerT, MitchellE, BergmeierL, SinghM, SpallekR, et al. (2000) The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol 30: 2245–2256.
42. KeeleBF, GiorgiEE, Salazar-GonzalezJF, DeckerJM, PhamKT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552–7557.
43. LiH, BarKJ, WangS, DeckerJM, ChenY, et al. (2010) High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 6: e1000890.
44. MillerCJ, LiQ, AbelK, KimEY, MaZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217–9227.
45. Salazar-GonzalezJF, SalazarMG, KeeleBF, LearnGH, GiorgiEE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273–1289.
46. KarlssonI, MalleretB, BrochardP, DelacheB, CalvoJ, et al. (2007) Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques. J Virol 81: 13456–13468.
47. Benlhassan-ChahourK, PenitC, DioszeghyV, VasseurF, JanvierG, et al. (2003) Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy. J Virol 77: 12479–12493.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2013 Číslo 12
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Influence of Mast Cells on Dengue Protective Immunity and Immune Pathology
- Myeloid Dendritic Cells Induce HIV-1 Latency in Non-proliferating CD4 T Cells
- Host Defense via Symbiosis in
- Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity